SCHEMBL6537404

SCHEMBL6537404

CC(C)(C)[Si](OCc1c(CBr)cnc2c(NC(=O)c3c(Cl)cccc3Cl)cccc12)(c1ccccc1)c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC16A3 O15427 1/20 0.36
GHSR Q92847 2/20 0.35
TMEM97 Q5BJF2 1/20 0.34
SIGMAR1 Q99720 1/20 0.34
SMN1; SMN2 Q16637 4/20 0.33
LMNA P02545 4/20 0.33
TYK2 P29597 3/20 0.33
HTT P42858 2/20 0.33
MAPT P10636 2/20 0.33
TSHR P16473 2/20 0.33
JAK2 O60674 2/20 0.33
JAK1 P23458 2/20 0.33
KMT2A Q03164 5/20 0.33
MEN1 O00255 3/20 0.33
CRHBP P24387 1/20 0.33
CRHR2 Q13324 1/20 0.33
PTGES O14684 1/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
ABL1 P00519 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537510 0.93 SLC16A3 (0.37) SLC16A3GHSRSMN1; SMN2LMNATYK2
SCHEMBL6537544 0.92 PTGES (0.37) SLC16A3GHSRSMN1; SMN2LMNATYK2
SCHEMBL6537961 0.88 SLC16A3 (0.41) SLC16A3GHSRSMN1; SMN2LMNATYK2
SCHEMBL6538571 0.88 SLC16A3 (0.38) SLC16A3GHSRSMN1; SMN2LMNATYK2
SCHEMBL8471310 0.87 SLC16A3 (0.36) SLC16A3GHSRSMN1; SMN2LMNATYK2
SCHEMBL6537655 0.83 GHSR (0.34) SLC16A3GHSRSMN1; SMN2LMNAHTT
SCHEMBL8588641 0.81 SLC16A3 (0.41) SLC16A3GHSRSMN1; SMN2LMNATYK2
SCHEMBL6538360 0.80 CYP3A4 (0.40) SLC16A3GHSRTMEM97SIGMAR1SMN1; SMN2
SCHEMBL6537759 0.77 PTGES (0.44) SLC16A3GHSRSMN1; SMN2LMNATYK2
SCHEMBL6537405 0.77 SLC16A3 (0.35) SLC16A3TMEM97SIGMAR1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed